▶ 調査レポート

世界の多発性骨髄腫の治療市場：市場規模・現状・予測
• 英文タイトル：Global Multiple Myeloma Treatment Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の多発性骨髄腫の治療市場：市場規模・現状・予測 / Global Multiple Myeloma Treatment Market Size, Status and Forecast 2019-2025 / QYR9N7601資料のイメージです。• レポートコード：QYR9N7601
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、多発性骨髄腫の治療のグローバル市場について調査・分析したレポートで、種類別（プロテアソーム阻害剤、免疫調節剤（IMiD）、ヒストンデアセチラーゼ（HDAC）阻害剤、免疫療法、細胞毒性化学療法）、用途別（病院、診療所、がん治療とリハビリセンター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・多発性骨髄腫の治療の世界市場規模
・主要企業別市場シェア
・多発性骨髄腫の治療の世界市場規模：種類別（プロテアソーム阻害剤、免疫調節剤（IMiD）、ヒストンデアセチラーゼ（HDAC）阻害剤、免疫療法、細胞毒性化学療法）
・多発性骨髄腫の治療の世界市場規模：用途別（病院、診療所、がん治療とリハビリセンター）
・多発性骨髄腫の治療のアメリカ市場規模（種類別、用途別）
・多発性骨髄腫の治療のヨーロッパ市場規模（種類別、用途別）
・多発性骨髄腫の治療の中国市場規模（種類別、用途別）
・多発性骨髄腫の治療の日本市場規模（種類別、用途別）
・多発性骨髄腫の治療の東南アジア市場規模（種類別、用途別）
・多発性骨髄腫の治療のインド市場規模（種類別、用途別）
・多発性骨髄腫の治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・多発性骨髄腫の治療の世界市場予測（2019年-2025年）
・多発性骨髄腫の治療の地域別市場予測（2019年-2025年）
...

Multiple myeloma is a cancer formed due to malignant plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system. Plasma cells helps to fight infections by making antibodies that recognize and attack germs. Multiple myeloma causes cancer cells to accumulate in the bone marrow, where they crowd out healthy blood cells. These malignant plasma cells then produce abnormal proteins (m protein) which may cause tumors, damage the kidneys, and impair immune system function.The global Multiple Myeloma market is anticipated to be mainly driven by increase in ageing population, rising obese population, increase in healthcare expenditure and increased penetration of novel cancer drugs. Some of the significant developments of this industry include upcoming new innovative products in the market, trend of combination therapies, and chance of new players.
In 2018, the global Multiple Myeloma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Multiple Myeloma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Multiple Myeloma Treatment development in United States, Europe and China.

The key players covered in this study
Johnson & Johnson
Roche Holding
Sanofi
Eli Lilly
Novartis
…

Market segment by Type, the product can be split into
Proteasome Inhibitors
Immunomodulatory Agents (IMiDs)
Histone Deacetylase (HDAC) Inhibitors
Immunotherapy
Cytotoxic Chemotherapy

Market segment by Application, split into
Hospitals
Clinics
Cancer Treatment and Rehabilitation Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Multiple Myeloma Treatment status, future forecast, growth opportunity, key market and key players.
To present the Multiple Myeloma Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Multiple Myeloma Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Multiple Myeloma Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Proteasome Inhibitors
1.4.3 Immunomodulatory Agents (IMiDs)
1.4.4 Histone Deacetylase (HDAC) Inhibitors
1.4.5 Immunotherapy
1.4.6 Cytotoxic Chemotherapy
1.5 Market by Application
1.5.1 Global Multiple Myeloma Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Cancer Treatment and Rehabilitation Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Multiple Myeloma Treatment Market Size
2.2 Multiple Myeloma Treatment Growth Trends by Regions
2.2.1 Multiple Myeloma Treatment Market Size by Regions (2014-2025)
2.2.2 Multiple Myeloma Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Multiple Myeloma Treatment Market Size by Manufacturers
3.1.1 Global Multiple Myeloma Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Multiple Myeloma Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Multiple Myeloma Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Multiple Myeloma Treatment Key Players Head office and Area Served
3.3 Key Players Multiple Myeloma Treatment Product/Solution/Service
3.4 Date of Enter into Multiple Myeloma Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Multiple Myeloma Treatment Market Size by Type (2014-2019)
4.2 Global Multiple Myeloma Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Multiple Myeloma Treatment Market Size (2014-2019)
5.2 Multiple Myeloma Treatment Key Players in United States
5.3 United States Multiple Myeloma Treatment Market Size by Type
5.4 United States Multiple Myeloma Treatment Market Size by Application

6 Europe
6.1 Europe Multiple Myeloma Treatment Market Size (2014-2019)
6.2 Multiple Myeloma Treatment Key Players in Europe
6.3 Europe Multiple Myeloma Treatment Market Size by Type
6.4 Europe Multiple Myeloma Treatment Market Size by Application

7 China
7.1 China Multiple Myeloma Treatment Market Size (2014-2019)
7.2 Multiple Myeloma Treatment Key Players in China
7.3 China Multiple Myeloma Treatment Market Size by Type
7.4 China Multiple Myeloma Treatment Market Size by Application

8 Japan
8.1 Japan Multiple Myeloma Treatment Market Size (2014-2019)
8.2 Multiple Myeloma Treatment Key Players in Japan
8.3 Japan Multiple Myeloma Treatment Market Size by Type
8.4 Japan Multiple Myeloma Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Multiple Myeloma Treatment Market Size (2014-2019)
9.2 Multiple Myeloma Treatment Key Players in Southeast Asia
9.3 Southeast Asia Multiple Myeloma Treatment Market Size by Type
9.4 Southeast Asia Multiple Myeloma Treatment Market Size by Application

10 India
10.1 India Multiple Myeloma Treatment Market Size (2014-2019)
10.2 Multiple Myeloma Treatment Key Players in India
10.3 India Multiple Myeloma Treatment Market Size by Type
10.4 India Multiple Myeloma Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Multiple Myeloma Treatment Market Size (2014-2019)
11.2 Multiple Myeloma Treatment Key Players in Central & South America
11.3 Central & South America Multiple Myeloma Treatment Market Size by Type
11.4 Central & South America Multiple Myeloma Treatment Market Size by Application

12 International Players Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Company Details
12.1.2 Company Description and Business Overview
12.1.3 Multiple Myeloma Treatment Introduction
12.1.4 Johnson & Johnson Revenue in Multiple Myeloma Treatment Business (2014-2019)
12.1.5 Johnson & Johnson Recent Development
12.2 Roche Holding
12.2.1 Roche Holding Company Details
12.2.2 Company Description and Business Overview
12.2.3 Multiple Myeloma Treatment Introduction
12.2.4 Roche Holding Revenue in Multiple Myeloma Treatment Business (2014-2019)
12.2.5 Roche Holding Recent Development
12.3 Sanofi
12.3.1 Sanofi Company Details
12.3.2 Company Description and Business Overview
12.3.3 Multiple Myeloma Treatment Introduction
12.3.4 Sanofi Revenue in Multiple Myeloma Treatment Business (2014-2019)
12.3.5 Sanofi Recent Development
12.4 Eli Lilly
12.4.1 Eli Lilly Company Details
12.4.2 Company Description and Business Overview
12.4.3 Multiple Myeloma Treatment Introduction
12.4.4 Eli Lilly Revenue in Multiple Myeloma Treatment Business (2014-2019)
12.4.5 Eli Lilly Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Multiple Myeloma Treatment Introduction
12.5.4 Novartis Revenue in Multiple Myeloma Treatment Business (2014-2019)
12.5.5 Novartis Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Multiple Myeloma Treatment Key Market Segments
Table Key Players Multiple Myeloma Treatment Covered
Table Global Multiple Myeloma Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Multiple Myeloma Treatment Market Size Market Share by Type 2014-2025
Figure Proteasome Inhibitors Figures
Table Key Players of Proteasome Inhibitors
Figure Immunomodulatory Agents (IMiDs) Figures
Table Key Players of Immunomodulatory Agents (IMiDs)
Figure Histone Deacetylase (HDAC) Inhibitors Figures
Table Key Players of Histone Deacetylase (HDAC) Inhibitors
Figure Immunotherapy Figures
Table Key Players of Immunotherapy
Figure Cytotoxic Chemotherapy Figures
Table Key Players of Cytotoxic Chemotherapy
Table Global Multiple Myeloma Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Cancer Treatment and Rehabilitation Centers Case Studies
Figure Multiple Myeloma Treatment Report Years Considered
Table Global Multiple Myeloma Treatment Market Size 2014-2025 (Million US$)
Figure Global Multiple Myeloma Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Multiple Myeloma Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Multiple Myeloma Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Multiple Myeloma Treatment Market Share by Regions 2014-2019
Figure Global Multiple Myeloma Treatment Market Share by Regions 2014-2019
Figure Global Multiple Myeloma Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Multiple Myeloma Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Multiple Myeloma Treatment Market Share by Manufacturers (2014-2019)
Figure Global Multiple Myeloma Treatment Market Share by Manufacturers in 2018
Table Global Multiple Myeloma Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Multiple Myeloma Treatment Product/Solution/Service
Table Date of Enter into Multiple Myeloma Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Multiple Myeloma Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Multiple Myeloma Treatment Market Size Share by Type (2014-2019)
Figure Global Multiple Myeloma Treatment Market Size Market Share by Type (2014-2019)
Table Global Multiple Myeloma Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Multiple Myeloma Treatment Market Size Share by Application (2014-2019)
Figure Global Multiple Myeloma Treatment Market Size Market Share by Application (2014-2019)
Figure Global Multiple Myeloma Treatment Revenue Market Share by Application in 2018
Figure United States Multiple Myeloma Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Multiple Myeloma Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Multiple Myeloma Treatment Market Share (2018-2019)
Table United States Multiple Myeloma Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Multiple Myeloma Treatment Market Share by Type (2014-2019)
Table United States Multiple Myeloma Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Multiple Myeloma Treatment Market Share by Application (2014-2019)
Figure Europe Multiple Myeloma Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Multiple Myeloma Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Multiple Myeloma Treatment Market Share (2018-2019)
Table Europe Multiple Myeloma Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Multiple Myeloma Treatment Market Share by Type (2014-2019)
Table Europe Multiple Myeloma Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Multiple Myeloma Treatment Market Share by Application (2014-2019)
Figure China Multiple Myeloma Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Multiple Myeloma Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Multiple Myeloma Treatment Market Share (2018-2019)
Table China Multiple Myeloma Treatment Market Size by Type (2014-20189) (Million US$)
Table China Multiple Myeloma Treatment Market Share by Type (2014-2019)
Table China Multiple Myeloma Treatment Market Size by Application (2014-2019) (Million US$)
Table China Multiple Myeloma Treatment Market Share by Application (2014-2019)
Figure Japan Multiple Myeloma Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Multiple Myeloma Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Multiple Myeloma Treatment Market Share (2018-2019)
Table Japan Multiple Myeloma Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Multiple Myeloma Treatment Market Share by Type (2014-2019)
Table Japan Multiple Myeloma Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Multiple Myeloma Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Multiple Myeloma Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Multiple Myeloma Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Multiple Myeloma Treatment Market Share (2018-2019)
Table Southeast Asia Multiple Myeloma Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Multiple Myeloma Treatment Market Share by Type (2014-2019)
Table Southeast Asia Multiple Myeloma Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Multiple Myeloma Treatment Market Share by Application (2014-2019)
Figure India Multiple Myeloma Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Multiple Myeloma Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Multiple Myeloma Treatment Market Share (2018-2019)
Table India Multiple Myeloma Treatment Market Size by Type (2014-2019) (Million US$)
Table India Multiple Myeloma Treatment Market Share by Type (2014-2019)
Table India Multiple Myeloma Treatment Market Size by Application (2014-2019) (Million US$)
Table India Multiple Myeloma Treatment Market Share by Application (2014-2019)
Figure Central & South America Multiple Myeloma Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Multiple Myeloma Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Multiple Myeloma Treatment Market Share (2018-2019)
Table Central & South America Multiple Myeloma Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Multiple Myeloma Treatment Market Share by Type (2014-2019)
Table Central & South America Multiple Myeloma Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Multiple Myeloma Treatment Market Share by Application (2014-2019)
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Multiple Myeloma Treatment Business (2014-2019) (Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Multiple Myeloma Treatment Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Roche Holding Company Details
Table Roche Holding Revenue in Multiple Myeloma Treatment Business (2014-2019)(Million US$)
Figure Roche Holding Revenue Growth Rate in Multiple Myeloma Treatment Business (2014-2019)
Table Roche Holding Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Multiple Myeloma Treatment Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Multiple Myeloma Treatment Business (2014-2019)
Table Sanofi Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Multiple Myeloma Treatment Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Multiple Myeloma Treatment Business (2014-2019)
Table Eli Lilly Recent Development
Table Novartis Company Details
Table Novartis Revenue in Multiple Myeloma Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Multiple Myeloma Treatment Business (2014-2019)
Table Novartis Recent Development
Table Global Multiple Myeloma Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Multiple Myeloma Treatment Market Size Share by Regions (2019-2025)
Figure Global Multiple Myeloma Treatment Market Size Share by Regions in 2025
Figure United States Multiple Myeloma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Multiple Myeloma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Multiple Myeloma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Multiple Myeloma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Multiple Myeloma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Multiple Myeloma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Multiple Myeloma Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Multiple Myeloma Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Multiple Myeloma Treatment Market Size by Product (2019-2025)
Figure Global Multiple Myeloma Treatment Market Size by Product in 2025
Table Global Multiple Myeloma Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Multiple Myeloma Treatment Market Size by Application (2019-2025)
Figure Global Multiple Myeloma Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の進行性再発性多発性硬化症治療市場2019
    Global Progressive Relapsing Multiple Sclerosis Treatment Sales Market Report 2019
    QYR9N3775 2019年6月13日 106Pages
    本調査レポートでは、進行性再発性多発性硬化症治療の世界市場について調査・分析し、進行性再発性多発性硬化症治療のメーカー別販売量、市場シェア分析、種類別販売分析（COG-133、GZ-402668、イネビリズマブ、VCE-0032、その他）、用途別販売分析（診療所、Hopital、その他）、地域別販売...
  • 世界の一次進行型多発性硬化症の治療市場2019
    Global Primary Progressive Multiple Sclerosis Treatment Sales Market Report 2019
    QYR9N3747 2019年6月13日 107Pages
    本調査レポートでは、一次進行型多発性硬化症の治療の世界市場について調査・分析し、一次進行型多発性硬化症の治療のメーカー別販売量、市場シェア分析、種類別販売分析（ApE、ビオチン、GZ-402668、イブジラスト、イデベノン、その他）、用途別販売分析（病院、診療所、その他）、地域別販売分析（米国、ヨー...
  • 世界の結節性痒疹の治療市場：市場規模・現状・予測
    Global Prurigo Nodularis Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7901 2019年6月14日 93Pages
    当資料は、結節性痒疹の治療のグローバル市場について調査・分析したレポートで、種類別（カプサイシンクリーム、抗ヒスタミン薬、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれて...
  • 世界の汗腺炎掻爬治療市場：市場規模・現状・予測
    Global Hidradenitis Suppurativa Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7295 2019年6月14日 99Pages
    当資料は、汗腺炎掻爬治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・汗腺炎...
  • 世界の外側上顆炎治療市場：市場規模・現状・予測
    Global Lateral Epicondylitis Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7439 2019年6月14日 96Pages
    当資料は、外側上顆炎治療のグローバル市場について調査・分析したレポートで、種類別（非外科療法、外科療法）、用途別（運動選手、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・外側上...
  • 世界のサイトメガロウイルス治療市場：市場規模・現状・予測
    Global Cytomegalovirus Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7060 2019年6月14日 97Pages
    当資料は、サイトメガロウイルス治療のグローバル市場について調査・分析したレポートで、種類別（ガンシクロビル、バルガンシクロビル、フォスカーネット、シドフォビル、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模...
  • 世界の目のアレルギー治療市場：市場規模・現状・予測
    Global Eye Allergy Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7187 2019年6月14日 93Pages
    当資料は、目のアレルギー治療のグローバル市場について調査・分析したレポートで、種類別（薬、アレルギーショット、その他）、用途別（病院、アイクリニック）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の坐骨神経痛の治療市場：市場規模・現状・予測
    Global Sciatica Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8000 2019年6月14日 96Pages
    当資料は、坐骨神経痛の治療のグローバル市場について調査・分析したレポートで、種類別（）、用途別（）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・坐骨神経痛の治療の世界市場規模
  • 世界の外科的外側上顆炎治療市場：市場規模・現状・予測
    Global Surgical Lateral Epicondylitis Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8093 2019年6月14日 90Pages
    当資料は、外科的外側上顆炎治療のグローバル市場について調査・分析したレポートで、種類別（関節鏡手術、開腹手術）、用途別（運動選手、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・...
  • 世界の尿道炎の治療市場：市場規模・現状・予測
    Global Urethritis Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8156 2019年6月14日 94Pages
    当資料は、尿道炎の治療のグローバル市場について調査・分析したレポートで、種類別（鎮痛剤、抗菌、抗ウイルス薬、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の進行性再発性多発性硬化症治療市場2019世界の進行性再発性多発性硬化症治療市場2019 The global Progressive Relapsing Multiple Sclerosis Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Progressive Relapsing Multiple Sclerosis Treatment market status and forecast, c…
  • 世界のヒストンデアセチラーゼ8市場2019世界のヒストンデアセチラーゼ8市場2019 The global Histone Deacetylase 8 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Histone Deacetylase 8 market status and forecast, categorizes the global Histone Deacetylase 8 market size (v…
  • 世界の一次進行型多発性硬化症の治療市場2019世界の一次進行型多発性硬化症の治療市場2019 The global Primary Progressive Multiple Sclerosis Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Primary Progressive Multiple Sclerosis Treatment market status and forecast, categ…
  • 世界のCox-2阻害剤市場：市場規模・現状・予測世界のCox-2阻害剤市場：市場規模・現状・予測 Cox-2 Inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, Cox-2, an enzyme responsible for inflammation and pain. These drugs are responsible for decreasing the production of prostaglandins.In 2018, the global Cox-2 Inhibitors market size was …
  • 世界のシグナル伝達阻害剤市場：市場規模・現状・予測世界のシグナル伝達阻害剤市場：市場規模・現状・予測 Signal transduction inhibitors are drugs that may prevent the ability of cancer cells to multiply quickly and invade other tissues.Growing need for effective cancer diagnostics and innovative therapies for cancer treatment are expected to be the major factors driving the signal transduction inhibito…